JW Pharmaceutical Corp (001067) — Cash Flow Quality Index
JW Pharmaceutical Corp (001067) has a Cash Flow Quality Index of 1.53x as of September 2025. Operating cash flow of ₩46.92 Billion exceeds net income of ₩30.59 Billion, indicating high earnings quality where cash backs reported profits. Explore JW Pharmaceutical Corp cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
JW Pharmaceutical Corp Cash Flow Quality Index (2015–2024)
Historical Cash Flow Quality Index for JW Pharmaceutical Corp across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 001067 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for JW Pharmaceutical Corp (2015–2024)
Year-by-year earnings quality comparison for JW Pharmaceutical Corp. For live market cap and the full company financial profile, see JW Pharmaceutical Corp market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.22x | ₩79.39 Billion | ₩65.04 Billion | ▼ -51.2% |
| 2023 | 2.50x | ₩87.16 Billion | ₩34.84 Billion | ▲ +47.8% |
| 2022 | 1.69x | ₩56.76 Billion | ₩33.55 Billion | ▼ -73.8% |
| 2018 | 6.47x | ₩52.11 Billion | ₩8.06 Billion | ▲ +403.9% |
| 2015 | -2.13x | ₩-4.17 Billion | ₩1.96 Billion | — |